The biomarker that predicts response to radiation therapy (RT) and immune checkpoint blockade (ICB) treatment combination for lung cancer patients has been identified.
In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells.
Recent advances in cancer treatment have focused on developing immune checkpoint blockers, which have ...
The biomarker that predicts response to radiation therapy (RT) and immune checkpoint blockade (ICB) treatment combination for lung cancer patients has been identified.
In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells.
Recent advances in cancer treatment have focused on developing immune checkpoint blockers, which have ...